Leena Sarelin

1.1k total citations
9 papers, 666 citations indexed

About

Leena Sarelin is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Leena Sarelin has authored 9 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 5 papers in Genetics and 4 papers in Molecular Biology. Recurrent topics in Leena Sarelin's work include Pancreatic function and diabetes (6 papers), Diabetes and associated disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Leena Sarelin is often cited by papers focused on Pancreatic function and diabetes (6 papers), Diabetes and associated disorders (4 papers) and Metabolism, Diabetes, and Cancer (4 papers). Leena Sarelin collaborates with scholars based in Finland, Sweden and Australia. Leena Sarelin's co-authors include Leif Groop, Bo Isomaa, Marja‐Riitta Taskinen, Peter Almgren, Mikko Lehtovirta, Marianne Henricsson, Carol Forsblom, Markku Lehto, Bo Isomaa and Valeriya Lyssenko and has published in prestigious journals such as Journal of Clinical Investigation, Diabetes Care and Diabetologia.

In The Last Decade

Leena Sarelin

9 papers receiving 646 citations

Peers

Leena Sarelin

GENET

SURGE

EDM

MB

EPIDE

Marco Capizzi Italy

Rochelle N. Naylor United States

Iwona Pietrzak Poland

Maria Luisa Arpi Italy

Anthony J. Weinhaus United States

Jan Bruining Netherlands

C S Rose Denmark

A. Petrone Italy

J. A. Edge United Kingdom

Sukumar Nagendran United States

Marco Capizzi Italy

Leena Sarelin

598 ×1.2

GENET

420 ×1.0

SURGE

498 ×1.5

EDM

111 ×0.5

MB

38 ×0.8

EPIDE

Citations per year, relative to Leena Sarelin Leena Sarelin (= 1×) peers Marco Capizzi

Countries citing papers authored by Leena Sarelin

Since Specialization

Citations

This map shows the geographic impact of Leena Sarelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leena Sarelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leena Sarelin more than expected).

Fields of papers citing papers by Leena Sarelin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leena Sarelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leena Sarelin. The network helps show where Leena Sarelin may publish in the future.

Co-authorship network of co-authors of Leena Sarelin

This figure shows the co-authorship network connecting the top 25 collaborators of Leena Sarelin. A scholar is included among the top collaborators of Leena Sarelin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leena Sarelin. Leena Sarelin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Kettunen, Jarno L. T., Elina Rantala, Om Prakash Dwivedi, et al.. (2021). A multigenerational study on phenotypic consequences of the most common causal variant of HNF1A-MODY. Diabetologia. 65(4). 632–643. 13 indexed citations

2.

Almgren, Peter, Mikko Lehtovirta, Bo Isomaa, et al.. (2011). Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study. Diabetologia. 54(11). 2811–2819. 188 indexed citations

3.

Isomaa, Bo, et al.. (2007). Adolescents at Risk for MODY3 Diabetes Prefer Genetic Testing Before Adulthood. Diabetes Care. 30(6). 1571–1573. 5 indexed citations

4.

Isomaa, Bo, et al.. (2006). Improved Prandial Glucose Control With Lower Risk of Hypoglycemia With Nateglinide Than With Glibenclamide in Patients With Maturity-Onset Diabetes of the Young Type 3. Diabetes Care. 29(2). 189–194. 64 indexed citations

5.

Aktan–Collan, Katja, et al.. (2005). Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer. Diabetologia. 48(2). 242–250. 10 indexed citations

6.

Isomaa, Bo, et al.. (2002). Onset of glucose intolerance in MODY3 Pro291fsInsC mutation carrierscoincides with pubertal years - a prospective follow-up study. Diabetologia. 45. 129–129. 2 indexed citations

7.

Isomaa, Bo, Peter Almgren, Marianne Henricsson, et al.. (1999). Chronic complications in patients with slowly progressing autoimmune type 1 diabetes (LADA).. Diabetes Care. 22(8). 1347–1353. 88 indexed citations

8.

Isomaa, Bo, Marianne Henricsson, Markku Lehto, et al.. (1998). Chronic diabetic complications in patients with MODY3 diabetes. Diabetologia. 41(4). 467–473. 128 indexed citations

9.

Lehto, Markku, Melanie M. Mahtani, Elisabeth Widén, et al.. (1997). Characterization of the MODY3 phenotype. Early-onset diabetes caused by an insulin secretion defect.. Journal of Clinical Investigation. 99(4). 582–591. 168 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact